Are Neogen Chemicals latest results good or bad?

Neogen Chemicals' latest financial results for the quarter ended September 2025 reveal a complex picture of operational performance. The company reported a consolidated net profit of ₹3.37 crores, which reflects a significant year-on-year decline of 69.25%. This sharp drop in profitability occurred despite achieving record revenue of ₹208.66 crores, marking a year-on-year increase of 7.91%. The operating margin, however, contracted to 14.36%, down from 17.85% in the same quarter last year, indicating challenges in maintaining profitability amidst rising costs. Notably, the company experienced a substantial increase in interest expenses, which surged to ₹19.48 crores, the highest on record, driven by its aggressive capacity expansion program. This has raised concerns regarding the company's debt serviceability, as evidenced by a decline in the interest coverage ratio to 1.54 times. On a sequential basis, the results show a decline in net profit of 67.15% from the previous quarter, despite a revenue growth of 11.74%. The financial performance reflects ongoing operational challenges, including margin compression and elevated leverage, which have contributed to a negative financial trend classification. Overall, Neogen Chemicals has seen an adjustment in its evaluation, reflecting the pressures on profitability and the implications of its current operational strategy. Investors and stakeholders may need to closely monitor future performance to assess the potential for recovery and improvement in financial metrics.